
<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Later Abortion Initiative</title>
<style>
  body {
    font-family: Arial, sans-serif;
    margin: 0;
    padding: 0;
  }
  header {
    background-color: #000;
    color: white;
    padding: 10px 20px;
    text-align: center;
  }
  .main-content {
    padding: 20px;
  }
  .menu {
    background-color: #eee;
    padding: 10px;
  }
  .menu ul {
    list-style-type: none;
    margin: 0;
    padding: 0;
  }
  .menu li {
    display: inline;
    margin-right: 10px;
  }
  .menu a {
    text-decoration: none;
    color: #000;
  }
  .breadcrumb {
    font-size: 0.9em;
    margin-bottom: 20px;
  }
  .breadcrumb span {
    color: #666;
  }
  h1, h2 {
    color: #333;
  }
  .content-section {
    margin-bottom: 20px;
  }
  .image-placeholder {
    width: 100%;
    height: auto;
    background-image: url('rick.jpg');
    background-size: cover;
    background-position: center;
  }
  .footer {
    background-color: #eee;
    padding: 10px;
    text-align: center;
    margin-top: 20px;
  }
</style>
</head>
<body>

<header>
  <h1>Later Abortion Initiative</h1>
  A project of Ibis Reproductive Health
</header>

<div class="menu">
  <ul>
    <li><a href="#">Home</a></li>
    <li><a href="#">The Initiative</a></li>
    <li><a href="#">Later Abortion</a></li>
    <li><a href="#">Resources</a></li>
  </ul>
</div>

<div class="main-content">
  <div class="breadcrumb">
    <a href="#">Home</a> > <span>You are here</span>
  </div>

  <h2>Clinical analysis of uterine artery embolization combined with double balloon catheter plus curettage for patients with placenta previa who underwent pregnancy termination and suffered antenatal massive hemorrhage in the 2nd trimester: Three case reports.</h2>

  <div class="content-section">
    <p>Tang F, Du S, Zhao Z, Sun G, Lin Y, Li R, Wu X</p>
    <p>Medicine</p>
    <p>Jan 2019</p>
    <p><a href="#">Link</a></p>
  </div>

  <div class="content-section">
    <h3>Rationale:</h3>
    <p>It is very difficult to treat patients with placenta previa who underwent pregnancy termination and suffered antenatal massive hemorrhage in the 2nd trimester.</p>
  </div>

  <div class="content-section">
    <h3>Patient concerns:</h3>
    <p>In this study, case 1 was with fetal malformation of 18-trisomy syndrome at gestation of 19 weeks + 2 days, case 2 was with fetal malformation of 18-trisomy syndrome at gestation of 22 weeks + 1 day, and case 3 was for intrauterine fetal death at gestation of 27 weeks. All the 3 cases were completely placenta previa.</p>
  </div>

  <div class="content-section">
    <h3>Diagnoses:</h3>
    <p>For the 3 patients, completely placenta previa was confirmed by ultrasound examination after hospitalization and underwent pregnancy termination for fetal death or fetal malformation in the 2nd trimester.</p>
  </div>

  <div class="content-section">
    <h3>Interventions:</h3>
    <p>The 3 patients with placenta previa underwent pregnancy termination by mifepristone combined with ethacridine lactate in the 2nd trimester for intrauterine fetal death or fetal malformation from June 2017 to May 2018, and suffered antenatal massive hemorrhage during termination. Uterine artery embolization (UAE) was immediately performed to achieve hemostasis, then double balloon catheter (DBC) was carried out to promote cervical ripen, at last curettage was implemented with the help of ultrasound.</p>
  </div>

  <div class="content-section">
    <h3>Outcomes:</h3>
    <p>The antenatal bleeding volume of these 3 patients were about 500, 600, and 550 mL. After implementing the combined treatment, all patients completed the abortion.</p>
  </div>

  <div class="content-section">
    <h3>Lessons:</h3>
    <p>The DBC-curettage combined treatment is safe and effective for patients with placenta previa who undergo pregnancy termination and suffered massive antenatal hemorrhage in the 2nd trimester. Future studies are needed to advance our observation.</p>
  </div>

  <div class="content-section">
    <h3>Tags:</h3>
    <p>Clinical research / standards</p>
  </div>

  <div class="content-section">
    <h2>About the Initiative</h2>
    <p>The Later Abortion Initiative (LAI), a project of Ibis Reproductive Health, will change the conversation around later abortion and the women who need this service. LAI particularly focuses on the increased stigma, challenges and barriers for women who need abortions after 18 weeks.</p>
  </div>

  <div class="content-section">
    <h2>A note on terminology and “late-term abortion”</h2>
    <ul>
      <li>Later Abortion Initiative</li>
      <li>Ibis Reproductive Health</li>
      <li>2067 Massachusetts Avenue, Suite 320</li>
      <li>Cambridge, MA 02140</li>
    </ul>
  </div>

  <div class="image-placeholder"></div>
</div>

<footer class="footer">
  Skip to main content
</footer>

</body>
</html>
